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ABSTRACT A new functionalization procedure was developed to replace cyltrimethylammoniumbromide coating on gold
nanorods (GNRs) fabricated through seed-mediated growth with chemically active alkanethiols; antibodies were then attached
to the GNRs to yield gold nanorod molecular probes (GNrMPs). The functionalization procedure was shown to minimize non-
speciﬁc binding. Multiplex sensing was demonstrated for three targets (goat anti-human IgG, goat anti-rabbit IgG, and goat anti-
mouse IgG) through the distinct response of the plasmon spectra of GNrMPs to binding events. Quantiﬁcation of the plasmonic
binding events and estimation of ligand binding kinetics tethered to these nanoscale structures was also demonstrated through
a mathematical approach. Evaluation of the experimental and theoretical data yields an afﬁnity constant Ka ¼ 1.34 3 107 M1,
which was in agreement with the IgG-antiIgG binding afﬁnity reported in the literature. The GNrMP sensors were found to be
highly speciﬁc and sensitive with the dynamic response in the range between 109 M and 106 M. The limit of detection of
GNrMPs was found to be in the low nanomolar range, and is a function of the binding afﬁnity: for a higher probe-target afﬁnity
pair, the limit of detection can be expected to reach femto molar levels. This technique can play a key role in developing tunable
sensors for sensitive and precise monitoring of biological interactions.
INTRODUCTION
The development of biosensors for detection, monitoring,
and characterization of a variety of molecular interactions is
important for disease diagnosis, drug discovery, proteomics,
and detection of biological warfare agents (1).
Fundamentally, a biosensor is constructed by coupling a
ligand to its receptor complement via an appropriate signal
transduction element (2). Various signal transduction mech-
anisms have been explored as biosensing schemes, including
optical (3,4), radioactive (5,6), electrochemical (7,8), piezo-
electric (9,10), magnetic (11,12), micromechanical (13,14),
IR and Raman spectroscopic (15,16), and mass spectrometric
(17,18). Although each of these methods has its individual
strengths and weakness, optical sensors that utilize the sur-
face plasmon resonance (SPR) phenomenon of planar gold
surfaces have shown potential and have become the method
of choice in many biosensing applications (4,19).
Other than macro-scaled SPR sensors using a planar gold
surface, several research groups have begun to develop micro/
nano scaled optical biosensors that utilize the unique optical
properties of gold/silver nanostructures (20–29). The optical
properties of gold/silver nano structures strongly depend on
both the particle size and shape and are related to the interac-
tion between the metal conduction electrons and the electric
ﬁeld component of the incident electromagnetic radiation,
which leads to strong, characteristic absorption in the visible
to infrared region of the spectrum (30).
In aqueous solutions, gold nano structures exhibit strong
plasmon bands depending on their geometric shape and size.
For spherical particles, a strong absorption band at;520 nm
due to the excitation of plasmons by incident light can be
readily observed (30). For nanorods, two distinct plasmon
bands, one associated with the transverse (;520 nm) mode
and the other with the longitudinal mode (usually.600 nm),
could be observed (30). Quadrupole plasmon modes have
also been reported for more complex structures such as prisms
(31). Biosensor applications (20–29) have been designed
based on the fact that the wavelength of these bands are
affected by changes in the dielectric properties in the close
vicinity of these structures (known as nanoSPR (20), or
localized surface plasmon resonance (21)) due to the binding
of ligands to the corresponding receptor molecules (i.e., anti-
bodies) immobilized onto the nanostructures through chemi-
or physisorption. Nanostructures to probe speciﬁc targets can
be fabricated by attaching target-speciﬁc antibodies to a
suitable chemical tether to these nano structures. The mag-
nitude of wavelength shift induced by target binding has
been correlated to the dielectric property variations in the
vicinity of these nanostructures. In general, the signal strength
induced by receptor-ligand binding is related to the number
of receptors and the number of bound ligands; therefore, by
measuring the wavelength shift it might be possible to obtain
quantitative information of the binding events.
When anisotropic particles such as nanorods are used to
fabricate gold nanorod molecular probes (GNrMPs), single
particle sensing could be achieved. Recently we have demon-
strated that GNrMPs made with gold nanorods of different
aspect ratios could be implemented in a multiplex mode to
detect presence/absence of multiple targets simultaneously
(29). However, in an earlier work the GNrMPs were only
partially functionalized and were prone to nonspeciﬁc
binding, and the detection of targets was not quantitatively
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interpreted. Van Duyne and co-workers (21) developed a
mathematical model to study the response of nanoSPR de-
vices from the binding of solution-phased streptavidin to
biotin molecules immobilized onto triangular silver nano-
structures fabricated on glass surface. Using this model, the
binding afﬁnity between streptavidin and biotin onto func-
tionalized silver nanostructures was estimated as 1011 M1,
which is considerably smaller than the binding afﬁnity be-
tween streptavidin and biotin in the solution phase, which is
1013–1015 M1. The signiﬁcant reduction in binding afﬁnity
could result from the restriction of free motion of the surface-
immobilized biotins or partial denaturation due to binding of
biomolecules to planar surfaces.
In this research, we introduce a simple but a novel meth-
odology to functionalize GNrMPs completely by replacing
the cyltrimethylammoniumbromide (CTAB) cap of the gold
nanorods (GNRs) with a chemically active alkanethiol cap
(11-mercaptoundecanoic acid (MUA)), which signiﬁcantly
reduces the nonspeciﬁc binding. Compared to other available
functionalization strategies for gold nanorods that involved
replacement of the CTAB bilayer by lecithin (32) and thiolated-
PEG (33), our procedure is very simple but effective due to
its ease of implementation and ﬂexibility to accommodate a
variety of biologically relevant molecules such as antibodies,
DNAs, etc.
A systematic study of the response of GNrMPs to changes
in dielectric properties (refractive indexes) in the vicinity is
presented and quantitative analysis of binding events is
provided. It is shown that these GNrMPs operate in a manner
similar to macro SPR sensors and it is possible to transduce
very small changes in refractive index near the surface of the
GNrMPs into a measurable wavelength shift. The GNrMPs
were found to be extremely sensitive and could measure the
targets at low nanomolar level. The design, fabrication, and
implementation of the GNrMP detection scheme are illus-
trated in Fig. 1.
EXPERIMENTAL SECTION
Fabrication and characterization of
gold nanorods
A seed-mediated growth procedure modiﬁed from that suggested by
Nikoobakht and El-Sayed (34) was used to fabricate gold nanorods in the
aspect ratio between 2.5 and 7. Details of the procedure were reported
elsewhere (29). Hexadecyltrimethylammoniumbromide (99%), benzyldi-
methylammoniumchloride hydrate (99%), sodium borohydride (99%),
L-ascorbic acid, goldIII chloride hydrate (.99%), and silver nitrate (.99%)
were all purchased from Sigma-Aldrich (St. Louis, MO) and used without
further puriﬁcation. Nanopure deionized and distilled water (18.2 MV) was
used for all experiments.
Assuming the density of the gold nanorods as equivalent to that of bulk
gold (19.30 g/cm3), an average mass of gold nanorods of different aspect
ratios could be calculated once their average sizes are determined by
transmission electron microscope (TEM). The concentration of atomic gold
in the solution of gold nanorods was determined by inductively coupled
plasmon atomic emission spectroscopy (ICP-AES). A gold atomic absorp-
tion standard solution (Sigma-Aldrich, St. Louis, MO) was used for
calibration in the ICP-AES experiments. Comparison of the concentration of
atomic gold in the nanorod solution to the average nanorod volume obtained
by TEM analysis yielded a molar concentration value in the range between
;10 and 30 nM for gold nanorods of different aspect ratios. The gold
nanorods were then concentrated to 100 nM by centrifugation. All subse-
quent characterization, activation, and functionalization were conducted
using these nanorod samples.
The yield and aspect ratios of gold nanorods was determined using TEM,
acquired with a Philips CM-100 TEM (Philips, Eindhoven, Netherlands)
operating at 100 kV, 200 mm condenser aperture, 70-mm objective aperture,
and a spot size 3. TEM grids were prepared by placing 1 ml of the nanorod
solution in a 400-mesh formvar-coated copper grid and evaporating the
solution at room temperature. Images were then captured using a Tietz F415
slow scan digital camera (TVIPS, Gauting, Germany) at 4K resolution. At
least 150;200 nanorods could be counted and measured per grid to provide
an estimate of the mean aspect ratio of these nanorods after the synthesis
step.
Absorption spectra of GNrMP samples through each stage of experi-
ments were measured using a Jasco V570 UV-Vis-NIR spectrophotometer
(Jasco, Easton, MD), in the wavelength range between 400 and 1500 nm.
The measured spectra were normalized by rescaling the maximum ab-
sorbance of the longitudinal plasmon peak to 1.
To evaluate the sensitivity of gold nanorods with different aspect ratios to
the changes in refractive indexes in the environment, sugar solutions (0.2
g/ml, 0.4 g/ml, 0.6 g/ml, 0.8 g/ml, 1 g/ml, 1.2 g/ml, 1.4 g/ml, and 1.6 g/ml) of
different refractive indexes (1.3547, 1.374, 1.3906, 1.407, 1.42, 1.428,
1.439, 1.445) were prepared, gold nanorods of each aspect ratio were sus-
pended in these sugar solutions, and their plasmon spectra were measured.
The shift in the longitudinal plasmon peaks were recorded and the sensitivity
factor S, deﬁned as the relative change in resonance wavelength with respect
to change in the refractive index of the surrounding medium, S ¼ dlres/dns
(35), was calculated.
Functionalization of gold nanorods to
synthesize GNrMPs
Biofunctionalization of the GNRs constitutes a two-step process:
In Step 1, termed the Activation Step, a chemical anchor layer was formed
on the nanorod surface to provide active functional groups to which
biological molecules (i.e., antibodies) can be covalently attached.
In Step 2, the Functionalization Step, biomolecules were covalently
linked to the anchor layer to produce GNrMPs for target speciﬁc
sensing (Fig. 1).
FIGURE 1 Fabrication, functionalization, and implementation of
GNrMPs.
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Although the high binding afﬁnity of alkanethiols to gold has been
widely utilized to chemically modify gold nanoparticle surface for biological
functionalization (36–39), it cannot be directly applied to CTAB-capped
gold nanorods because the tightly-packed CTAB bilayers on the side faces
of the gold nanorods block the access of alkanethiol molecules to the gold
surface. Spontaneous reaction of alkanethiol molecules with gold under
ambient temperature only occurs at the end faces of the gold nanorods to
produce partially activated gold nanorods (36–38). In partially activated
gold nanorods, the remaining CTAB, which is positively charged at
physiological pH and attracts negatively-charged proteins, can cause severe
nonspeciﬁc binding problems. To overcome this problem, the CTAB cap has
to be replaced completely. A procedure was developed in our lab, to remove
CTAB by elevating the temperature of the solution and the gold nanorods
were kept from aggregation by sonication. 11-mercaptoundecanoic acid
(MUDA) was used as an alkanethiol to react with gold nanorods to produce a
fully activated surface for biofunctionalization. Brieﬂy, the nanorods were
suspended in water at 20 nM, to 5 ml of this solution, 1 ml of 20 mMMUDA
in ethanol was added and the solution was kept at 60C under constant
sonication for 30 min, then the temperature was decreased to 30C and the
solution was kept under constant sonication for 3 h. Afterwards the solution
was subjected to chloroform extraction for three rounds and the gold
nanorods were collected by centrifugation and resuspended in phosphate-
buffered saline (PBS) buffer (pH 7.4, Sigma).
Once the MUDA SAM was formed, human and mouse IgGs were then
attached to the activated nanorods as follows: to 5 ml of the activated
nanorods (;100 nM), 1 ml of freshly prepared 0.4 M 1-ethyl, 3-(3-
dimethylaminopropyl) carbodiimide (EDAC) and 0.1 M 4-(4-maleimido-
phenyl) butyric acid N-succinimidyl ester (NHS) (both from Pierce
Biotechnology, Rockford, IL) solution were added and sonicated for 25
min at 4C. The resulting structures were then collected by centrifugation at
5000 rpm for 5 min and resuspended in 5 ml PBS buffer (pH ¼ 7.4). IgG
suspended in PBS was then added to the resulting nanorod suspension (the
concentration of IgG was varied between ;200 and 1000 nM) and then
incubated for 1 h under constant sonication at room temperature. The
functionalized nanorods were subsequently collected by centrifugation at
5000 rpm for 5 min and three rounds of vigorous washing and sonication in
PBS solution for 10 min. The supernatant was collected after each washing
step and the cumulative protein content was measured using a Bio-Rad
Protein Assay (Bio-Rad Laboratories, Hercules, CA) with bovine serum
albumin as a protein standard. The amount of IgGs bound to the nanorods
was determined by subtracting the IgGs left in the supernatant from the
original amount.
Implementation of the gold nanorod
molecular probes
Five milliliters of the GNrMPs (20 nM) was mixed with 5 ml of targets
(respective anti-IgGs) with concentrations spanning from 106 M to 109 M
for 30 min under mild stirring to allow the probe-target binding to reach
equilibrium and the sensor response to the probe-target binding depicted by
a pronounced shift of longitudinal plasmon peaks, as measured using UV-
Vis-NIR spectroscopy. For multiplex analysis, three GNrMPs with different
aspect ratios were mixed at equal concentrations, and the target solution
containing the respective complement (anti-IgGs) at varying concentrations
were prepared. Equal amount of GNrMP and target solutions were mixed
and kept under mild stirring for 30 min and the plasmon spectra of the
mixture were then measured. The response of GNrMPs to target binding
events was then quantitatively evaluated.
RESULTS AND DISCUSSION
Nanorods fabrication and characterization
Gold nanorods of aspect ratios in the range between 2.8 and
7 were fabricated using the single- and double-surfactant
protocols discussed earlier. For the aspect ratio considered, a
linear correlation could be established between the aspect
ratio of gold nanorods and the absorbance wavelength of the
longitudinal plasmon bands, as reported elsewhere (29); hence,
the aspect ratio of gold nanorods could be easily deduced
from their plasmon spectra.
TEM imaging of nanorods of various aspect ratios con-
ﬁrmed yields of 93.5–98.5%. Another observation is that the
width of nanorods (7;10 nm) remained approximately the
same; hence, an increase in aspect ratio was predominately
determined by elongation of nanorods.
A mathematical model based on the Drude free electron
model of metal proposed by Lee and El-Sayed in a recent
article (40) to explain the sensitivity of the wavelength of the
plasmon bands of gold nanorods to the refractive index of
their surroundings, deﬁned by a sensitivity factor, S, can be
expressed as
S ¼ dlres
dns
; (1)
where lres is the plasma wavelength of nanostructures, and ns
is the refractive index of the surroundings.
The wavelength of the plasmon bands of gold nanostruc-
tures is given by
lres
lp
¼ ðeb1 YesÞ1=2 ¼ ðeb1 Yn2s Þ1=2; (2)
where lp is the plasmon wavelength of bulk metal, eb
represents the interband contribution to the dielectric func-
tion of the gold nanostructure, es is the dielectric constant of
the surrounding medium, and Y is a geometric parameter pro-
portional to the square of aspect ratio (AR) of the nanorods,
Y } AR2. Hence
S ¼ dlres
dns
} lp
ﬃﬃﬃ
Y
p
} lp AR: (3)
Equation 3 shows that the sensitivity factor S of the surface
plasmon wavelength in response to changes in the refractive
index of the local environment depends on, among other
factors such as electron relaxation time and background
susceptibility, the type of metal through the bulk plasma
wavelength and the geometry of the nano structure, i.e., the
aspect ratio of the nanorods, and is linearly proportional to
both. Therefore, as the aspect ratio increases, the sensitivity
of the GNrMPs will increase.
Fig. 2 A shows the experimentally observed correlations
between maximum plasma wavelength and local refractive
index, over a range of 1.33–1.45, for gold nanorods with
ARs of 2.8, 3, 4.5, 5.5, and 7, respectively. The slopes of
the lines give the sensitivity factor S for each gold nanorod.
Fig. 2 B shows a correlation between S and aspect ratio to
be linear. Once aspect ratio is known, S can be readily
determined.
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Functionalization of gold nanorods to
make GNrMPs
After the full activation of GNRs, the CTAB layers on the
side face of these nanorods are replaced completely byMUDA.
It is known that the refractive index (RI) of the CTAB layer
(RI ¼ 1.435 (41)) is smaller than the RI of MUDA (RI ¼
1.463 (21)). However, the CTAB layer is a bilayer with a
thickness of 4;5 nm (39), which is larger than the thickness
of MUDA SAM (1.69 nm) (21). The effective local RI is
then due to the combined effect of the refractive index and
thickness of the layers in the vicinity of each gold nanorod.
Since the effective RI is higher before activation (1.414) a
blue shift of the plasmon bands is expected (effective RI after
activation is 1.392, calculated using Eqs. 7 and 8). Fig. 3
shows the plasmon spectra of GNRs with AR ¼ 2 before/
after complete activation. Blue shifts of 11.5 nm observed
matched well with the theoretical prediction (10.3 nm),
conﬁrming the complete activation of the nanorod surfaces.
Once the MUDA SAM is formed, biomolecules can be
covalently attached via the NH2 bond of the antibodies to
the COOH terminus of the MUDA SAM. A further red
shift of the plasmon peak can be observed due to antibody
functionalization. After the attachment of human IgG Fab,
these rods showed a signiﬁcant shift (of up to 20 nm) com-
pared to the unmodiﬁed rods. The sensitivity of the plasmon
spectra to the attachment of molecular layers forms the basis
of molecular biosensors using single particle SPR.
Although IgGs can only covalently attach to the MUDA
activated sites, physisorption of IgGs to CTAB capped side
faces is also possible for the partially activated rods. The
isoelectric point for IgG Fabs are;6 (42); under the reaction
pH (;7.4), the IgG Fabs are negatively charged, and thus
will bind to the positively charged CTAB cap due to elec-
trostatic interaction. To obtain GNrMPs that have consistent
IgG coating, the complete MUDA-activation route is nec-
essary, especially when low IgG/nanorod ratio is required to
quantify biomolecule interactions.
Responses of GNrMPs to target binding, as a
function of target (anti-IgG) concentration
Exposure of the GNrMPs of three different aspect ratios
(2.3, 3.5, and 5.1) (20 nM) to targets (anti-IgGs) of concen-
tration 1 mM or higher resulted in maximum SPR responses
(DRmax ¼ Dlmax) of 15, 21.5, and 33.2 nm, respectively,
depicting the saturation of GNrMPs with targets. When the
targets are present at lower concentrations, a corresponding
reduction in the response of GNrMPs (DR ¼ Dl) was ob-
served, implying an unsaturated state. The smallest mean-
ingful responses (;3 nm shift) that could be observed at
FIGURE 2 Sensitivity factor of GNrMPs. (A) Longitudinal wavelength
(llong_res) versus refractive indexes of the surrounding medium (ns) for
GNrMPs with varied aspect ratio (AR). (B) Plasmon sensitivity S versus AR.
FIGURE 3 Longitudinal plasmon band of GNR blue-shifts as response to
complete activation.
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target concentration as low as 90 nM, 20 nM, and 10 nM for
the three GNrMPs tested (an example is shown in Fig. 4, for
GNrMPs with AR ¼ 3.5) demonstrates that the sensitivity of
GNrMPs is tunable by controlling its aspect ratio.
The normalized GNrMP responses, DR/DRmax, are plotted
against the concentrations of the targets and shown in Fig. 5
for the three GNrMPs. The concentration range examined
varied from 109 M to 105 M. The DR/DRmax versus con-
centration curve could be quantitatively interpreted using
the steady-state binding kinetics model with the following
assumptions:
1. Binding between solution-phased targets (anti-IgGs) and
particle-bound capturing agents (IgGs) occurs by 1:1, with
invariant afﬁnities that are not affected by the antibody
immobilization;
2. The only operative GNrMP sensing mechanism is the
change in the local refractive index caused by binding
events; and
3. The measured nanoSPR response, DR, is determined by
the thickness, danalyte, of the absorbed analyte layer, and
its refractive index, nanalyte.
Treating each GNrMP as a single sensing platform, the equi-
librium surface excess that Gtargets expresses as the number of
molecules/cm2, for 1:1 binding of anti-IgG to particle-bound
IgG, is given by the Langmuir isotherm (21),
Gtarget
G
max
target
¼ Ka½Tð11Ka½TÞ; (4)
where Gmaxtarget is the saturation value of Gtargets (i.e., when
every capturing agent (IgGs) is saturated by the target (anti-
IgGs)), [T] is concentration of targets, and Ka is the apparent
afﬁnity constant for 1:1 binding of IgG to anti-IgG.
Adopting the model developed by Campbell and co-
workers (43) to analyze SPR responses to target binding, the
GNrMP response (R) to target binding is given by
R ¼ Sðneff  nextÞ; (5)
where S is the sensitivity factor of GNrMPs, deﬁned in Eq. 3;
next is the bulk refractive index of the external medium
(next ¼ nwater ¼ 1.33); and neff is the effective refractive
index of the quadralayer structure (layer 1 ¼ MUA SAM,
layer 2 ¼ IgG, layer 3 ¼ anti-IgG, and layer 4 ¼ water)
surrounding each GNrMP. S is determined experimentally
for each GNrMP. The effective refractive index of the quad-
ralayer structure is determined by integrating the distance-
dependent local refractive index, n(z), weighted by the square
of the local electromagnetic ﬁeld, E(z) as (43)
neff ¼ 2
ld
Z N
0
nðzÞE2ðzÞdz; (6)
where
nðzÞ ¼
nsam; 0# z# dsam
nIgG;dsam # z# dsam1 dIgG
nanti-IgG; dsam1 dIgG # z# dsam1 dIgG1 danti-IgG
nwater; dsam1 dIgG1 dantiIgG # z,N ð7Þ
:
8>><
>>:
Here nIgG ¼ nanti-IgG; dsam is the thickness of the MUDA
SAM; dIgG is the thickness of the IgG layer, which is the
same as danti-IgG; E(z) is assumed to be only dependent on the
local surface normal z; and ld is the characteristic decay length.
Although the electromagnetic ﬁeld surrounding these GNrMPs
FIGURE 4 The minimum and maximum observed
plasmon shifts for GNrMPs (AR ¼ 3.5) upon exposure to
anti-IgG targets. (Left) Response before and after 20 nM
target exposure;Dllong res¼ 3 nm. (Right) Response before
and after 1 mM target exposure, Dllong res ¼ 21.5 nm.
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is known to be more complex (44), this simple approxima-
tion was shown to sufﬁciently illustrate the behavior of silver
nanoSPR sensors (21), and will be adopted to illustrate the
GNrMP characteristics. The factor 2/ld normalizes the in-
tegral in Eq. 6 so that neff¼ nwater when n(z)¼ nwater for all z.
Van Duyne and co-workers (21) assumed exponential decay
for E(z), E(z) ¼ exp(z/ld), with ld ;5–6 nm, which was
consistent for a saturation distance of ;30 nm. The same
assumption is made in this work. Equation 6 can now be
evaluated and substituted into Eq. 5 to present the measured
response of GNrMPs as DR ¼ Rlayer3-Rlayer2,
DR ¼ SðnIgG  nwaterÞe
2dsam
ld

1 e
4dIgG
ld

; (8)
where dIgG ¼ dtarget (danti-IgG) is given by
dT
d
max
T
¼ Ka ½T
11Ka½T: (9)
The thickness of the SAM layer, dSAM, is approximated by
(21)
dSAM ¼ ax1 b; (10)
where x, the number of CH2 units in MUDA ¼ 10, a ¼ 0.13
nm, and b ¼ 0.66 nm (45).
The maximum GNrMP response, DRmax, for the target
(anti-IgGs) saturation level is
DRmax ¼ SðnIgG  nwaterÞe
2dsam
ld

1 e
4d
max
T
ld

: (11)
The DR/DRmax ratio depicts the predicted normalized GNrMP
response versus dT, which is directly related to target con-
centration, [T], through Eq. 9. Ka in Eq. 9 is the parameter to
be optimized to best ﬁt the experimental data.
To determine the best ﬁt experimental data, the following
experimentally determined values for the GNrMP-anti-IgG
system were used: S ¼ 152.4 3 AR 1 19.17 nm/RIU; AR is
the aspect ratio of the GNrMPs; nSAM ¼ 1.463 (21); nwater ¼
1.33; nIgG ¼ 1.41 (46); ld ¼ 6.0 nm; and dSAM ¼ 1.96 nm.
From saturation binding data of IgG to GNRs, the parameter
Gmaxtarget was found to be 2.13 3 10
2 molecules/nm2, which
yield a dT ¼ dIgG ¼ Gmaxtarget 3 VIgG. VIgG is approximated as
5.2 nm 3 5.2 nm * 5.2 nm (47), so dT ¼ 2.98 nm.
Using these parameters, for IgG-anti IgG binding, DRmax
is found to be related to the aspect ratio of GNrMPs as
DRmax ¼ 0:0409S ¼ 6:2333AR1 0:784: (12)
As shown in Fig. 5, this prediction matched well with the
experiment results.
The DR/DRmax versus [T] data in Fig. 5 could be best ﬁtted
with a Ka ¼ 1.34 3 107 M1. This Ka is consistent with the
binding afﬁnity reported in the literature for IgG-anti-IgG
binding (47–49), suggesting that the immobilization of IgGs
to gold nanorods did not signiﬁcantly reduce their binding
afﬁnity.
The DR/DRmax versus [T] relationship is independent of
the aspect ratio of GNrMPs; however, since the minimum
response (DRmin) that can be measured by the spectrometer is
ﬁxed (depends on instrumentation), with DRmax being larger
for GNrMPs with larger AR, the limit of detection (LOD ¼
DRmin/DRmax) could be lower. For the IgG-anti-IgG complex
studied, if AR ¼ 10, the LOD could reach ;1.8 nM (Eq. 9).
The LOD is thus a function of the ligand-receptor pair, and is
determined by the size of molecules (thickness of the
absorbed layers on the GNrMPs), the binding afﬁnity, and
the AR of GNrMPs.
The sensitivity of the GNrMPs is largely dependent on the
binding afﬁnity between the probes and their targets. For a
GNrMPs with AR ¼ 10, for protein-protein interactions, it
could be estimated (Eq. 9) that for Ka; 10
10 M1, the LOD
could reach fM level.
It should also be noticed that the dynamic range of the
GNrMP system for detecting IgG-anti-IgG interaction is
109 M to 107 M; within this range the response of the
nanoscale probes increases exponentially with respect to
target concentration. Therefore, the GNrMP scheme is an
excellent system for detecting targets in the nano molar range
and is comparable in sensitivity to ﬂuorescence methods (50).
Quantitative analysis of multiple targets using
GNrMPs in a multiplex fashion
A major advantage of the GNrMP scheme is its multiplexing
capability; by using GNrMPs with different aspect ratios,
multiple targets can be probed simultaneously. In this study,
GNrMPs with aspect ratios of 2.1, 4.5, and 6.5 functional-
ized with human IgG, rabbit IgG, and mouse IgG, respec-
tively, were used in equal proportion (5 ml, 20 nM) to the rod
FIGURE 5 Normalized GNrMP response, DR/DRmax, versus target con-
centration [T].
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concentration and incubated with a 10 ml target that
contained 100 nM of the respective anti-IgG counterpart
(20 nM goat anti-human IgG, 20 nM goat anti-rabbit IgG,
and 20 nM goat anti-mouse IgG) for 30 min under mild
stirring at 4C. Fig. 6 shows the plasmonic spectrum before/
after incubation with targets. Results in Table 1 show a
reasonable agreement with actual concentrations, demon-
strating that quantitative analysis of multiple targets could be
achieved from our proof of concept study.
Nonspeciﬁc binding studies
Selectivity of the MUDA-SAM-based GNrMP plasmonic
sensors is presented to demonstrate its application as a func-
tional sensor. Fully activated GNrMPs (AR ¼ 2.1) were
incubated with goat anti-human IgGs, without EDAC-NHS
mediated IgG coupling to eliminate the presence of cova-
lently-linked IgGs at the GNrMP surfaces. A 1 nm shift was
observed as the plasmon response of MDUA-activated
GNrMPs to the goat anti-human IgGs, which is comparable
to the peak-to-peak wavelength shift noise (0.5 nm, mea-
sured over ﬁve replications of the same sample). At a pH of
7.4, MUDA was deprotonated to become negatively-
charged, thereby minimizing the electronic repulsion be-
tween MUDA and anti-IgG to result in minimal or no
nonspeciﬁc binding. In our work, the minimum meaningful
plasmon response due to target binding was 3 nm, giving an
effective S/N ratio of ;3.
The nonspeciﬁc binding was also evaluated for multiplex
detection using mixtures of equal amount (5 ml, 20 nM) of
the three different GNrMPs used in multiplex experiments
(AR ¼ 2.1, 4.5, and 6.5, functionalized with MUDA with
human IgG, rabbit IgG, and mouse IgG, respectively) and
incubated with 10 ml of 100 nM goat anti-human IgGs for 30
min. The plasmon spectra before/after the incubation shown
in Fig. 7 indicates that even the most sensitive GNrMPs
(AR ¼ 6.5) responded by only a mere 0.8 nm red-shift,
suggesting negligible nonspeciﬁc binding for the detection
limits probed.
CONCLUSION
In this study we demonstrate a multiplex biosensor scheme
for quantitative measurement of biological interactions. The
LOD of the GNrMP scheme is determined by four factors:
the aspect ratio of the rod-based GNrMP, the binding af-
ﬁnity, the molecular size of the ligand receptors, and the
dielectric properties of the ligand-receptor complex. It was
found that the GNrMP-based binding afﬁnity calculations
were close to the GNR-IgG-anti-IgG complex, which is close
to the binding of free IgG-anti IgG. This is a major improve-
ment over the solid-substrate SPR sensor, where the motion
of surface-immobilized capturing molecules is restricted and
the binding afﬁnity is reduced by 2–3 orders in magnitude. It
has also been demonstrated that the selectivity of the GNrMP
scheme demonstrated to be in the nano molar range can be
improved signiﬁcantly by a full functionalization protocol to
minimize nonspeciﬁc binding. The concept and methodol-
ogy developed in this study can serve as the basis for
FIGURE 6 Quantitative analysis of multiple targets in a sample using
different GNrMPs shows plasmon red-shift due to GNrMPs binding to their
respective targets.
TABLE 1 Comparison of measured target concentration to
real values
Target 1 Target 2 Target 3
Real value 100 nM 20 nM 20 nM
Measured value 92.32 nM 19.14 nM 15.86 nM
FIGURE 7 Speciﬁc response of multiple GNrMPs to a single target,
demonstrating negligible nonspeciﬁc binding.
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evaluating detection limits and binding constants for a range
of biomolecular complexes.
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and Indiana University-Purdue University Indianapolis Walter Center grant
is acknowledged for supporting this work.
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